ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT04829383 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-10-01 → 2024-10-15 3. primary completion date: 2025-10-01 → 2024-06-19 4. enrollment: 50 → 6 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical